Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | TLN-372 |
| Trade Name | |
| Synonyms | TLN372|TLN 372 |
| Drug Descriptions |
Limited information is currently available on TLN-372, a putative pan-KRAS inhibitor (Oct 2025). |
| DrugClasses | KRAS Inhibitor 30 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cetuximab + TLN-372 | Cetuximab TLN-372 | 0 | 1 |
| Pembrolizumab + TLN-372 | Pembrolizumab TLN-372 | 0 | 1 |
| TLN-372 | TLN-372 | 0 | 1 |